BRD2 and colorectal carcinoma: However, LUAD, BRCA, and LIHC exhibited completely opposite to SMC-CRC- or TCGA-COAD-based finding, so the proportion of genes with significant HRs was significantly higher in tumor- than NAT-derived transcriptome; 22% NAT vs. 75% tumor for BRCA, 29% NAT vs. 64% tumor for LIHC, and 20% NAT vs. 77% tumor for LUAD (Fig. 6E–G).